Search

everythinglearnresearchcommunity

for

Search:↓

Most women with hair loss using 5% topical Minoxidil are satisfied with the treatment, but hair loss still affects their daily habits and social life.

Monocytes might be linked to hair loss after COVID-19.

Immune activities and specific genes are important in male pattern baldness.

Nanocarrier-based treatments show promise for better hair growth in androgenetic alopecia but need more research.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

Female pattern hair loss does not significantly affect sexual dysfunction.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Many women's hair loss is due to health issues, medication, nutrition, or stress.

Scalp biopsy and digital phototrichogram help diagnose and manage different types of diffuse hair loss.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Fibrosing alopecia in a pattern distribution is a type of hair loss that may often be overlooked, especially in men.

The conclusion is that detailed clinical descriptions help pathologists diagnose hair loss conditions more accurately.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

A Thai boy was diagnosed with a rare hair disorder causing hair thinning and shedding.

Adenosine lotion improves hair thickness and density in women with thinning hair.

Female androgenic alopecia causes hair thinning in women, especially after menopause, and affects their mental well-being.

Androgenetic alopecia in women needs more research and better management strategies.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Two young siblings experienced hair loss without hormone issues or other skin problems.

Biofibre® hair implants are safe and effective for alopecia when proper procedures are followed, with high patient satisfaction.

Possible causes of female hair loss include androgenetic alopecia, telogen effluvium, cicatricial alopecia, and alopecia areata incognita; diagnosis and treatment require dermoscopy and histopathology.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

TrichoScan often makes mistakes and needs improvement for correct hair growth analysis.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.